secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0000926617-23-000083
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health to restate 2022 and Q3 2022 financials due to warrant accounting error
--------------------------------------------------------------------------------

- Warrant liability fair value corrected from $7.75M to $3.98M, a $3.77M overstatement.
- Offering cost allocation adjusted: $543K moved from G&A expense to equity; $574K reclassified to non-operating expense.
- Material weakness identified in internal control over financial reporting related to complex transaction accounting.
- Error has no effect on cash, cash equivalents, or revenues; cash flow classification also corrected.
- Company will amend 2022 10-K and restate Q3 2022 10-Q; steps underway to remediate controls.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000083/0000926617-23-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000083/awh-20231013x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-23-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer